| By PR Newswire | Article Rating: |
|
| September 20, 2012 07:08 PM EDT | Reads: |
172 |
SAN ANTONIO, Sept. 20, 2012 /PRNewswire/ -- Aficionados have been calling HGH the "Fountain of Youth" for years because of its purported ability to reduce body fat, increase lean muscle mass, boost mood, strengthen bones, heighten sex drive, give you plenty of energy and get rid of wrinkles… making you look and feel decades — not years, but decades — younger. So is there really a pill that can match human growth hormone (HGH) injections? Friday evening in an exclusive event in the Exhibit Hall of the San Antonio Convention Center we just might find out.
The prestigious Obesity Society's 30th Annual Scientific Meeting will be host to one of the most highly anticipated research presentations of the past decade. More than 500 of the world's most well-respected scientists from around the globe will be gathered to hear the research results on an oral pill, in fact a dietary supplement called SeroVital-hgh from SanMedica International, which may be capable of increasing serum (blood) growth hormone levels.
Once the province of competitive athletes, human growth hormone has gone mainstream now that women have discovered its purported ability to reduce body fat, increase muscle tone, smooth out wrinkled skin, provide plenty of energy, and make them look and feel years younger. With all the interest being generated by the likes of Dr. Oz, Fox News, The Today Show, Vanity Fair, etc., this presentation is destined to draw quite a bit of interest at the conference.
The presentation will take place Friday, September 21, 2012 from 6:00-7:30 p.m. in the Exhibit Hall of the San Antonio Convention Center.
©2012 All Rights Reserved
SOURCE SanMedica International
Published September 20, 2012 Reads 172
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

